TARGET3D: high efficacy of 8 weeks paritaprevir/ritonavir/ombitasvir and dasabuvir among people with recent genotype 1 HCV infectionM. Martinello,M. Cerrone,S. Bhagani,E. Gane,C. Orkin,G. Cooke, G. J. Dore,K. Petoumenos,T. L. Applegate,E. Tu,P. Marks,N. Pagani, A. Schoolmeesters,J. Grebely, M. Nelson,G. V. MatthewsHIV MEDICINE(2018)引用 0|浏览21暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要